Abstract

Oral Sessions

Day 3, May 19(Fri.) 9:10-9:50 Room B (102)

Mapping the brain neurotransmitter network with mass spectrometry imaging directly in tissue sections

(1Biomolecular Mass Spectrometry Imaging Uppsala Univ, 2Organic Pharmaceutical Chemistry Uppsala Univ, 3Karolinska Univ Hospital, 4Bruker Daltonik)
Mohammadreza Shariatgorji1, Luke Odell2, Anna Nilsson1, Elva Fridjonsdottir1, Luay Katan2, Jonas Sävmarker2, Mattias Witt4, Per Svenningsson3, oPer Andren1

Small-molecule neurotransmitters, their precursors and metabolites are involved in the brain chemical network and transmit signals between neurons. Changes in their concentrations are associated with numerous normal neuronal processes, such as sleep and aging, but also in several disease states, including neurological disorders (e.g., Parkinson's and Alzheimer's disease), depression and drug addiction. Knowledge about their relative abundance and spatial distribution would provide insights into these complex neurological processes and disorders. At present, researchers rely on indirect histochemical, immunohistochemical, and ligand-based assays to detect these small-molecule transmitter substances. Current neuroimaging techniques have very limited abilities to directly identify and quantify neurotransmitters from brain sections.